S1PR1 and lymphoma: Three S1PR inhibitors (W146 for S1PR1, CAY10444 for S1PR3, and FTY720 for S1PR1–5) were selected to demonstrate the hypothesis that S1P signaling could mediate the HIPPO pathway in lymphoma cells (Fig. 4C).